Somatostatin receptor scintigraphy in medullary thyroid carcinoma.

@article{Tisell1997SomatostatinRS,
  title={Somatostatin receptor scintigraphy in medullary thyroid carcinoma.},
  author={L. E. Tisell and Hakan BJ Ahlman and Bo W{\"a}ngberg and G{\"o}ran V. Hansson and Johan M{\"o}lne and Ola Nilsson and G{\"o}ran Lindstedt and Martha Fj{\"a}lling and Eva Forssell-Aronsson},
  journal={The British journal of surgery},
  year={1997},
  volume={84 4},
  pages={543-7}
}
BACKGROUND 111In-radiolabelled (DTPA-D-Phe1)-octreotide scintigraphy can be used to localize neuroendocrine tumours expressing somatostatin receptors (SSTRs). The aim of this paper was to analyse the importance of tumour volume and growth for the visualization by SSTR scintigraphy of metastases from medullary thyroid carcinoma (MTC). METHODS Serum calcitonin concentrations were used to estimate volume and growth rate of MTC. Twenty-two patients who had persistent hypercalcitoninaemia after… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

Nuclear Oncology

Springer International Publishing • 2017
View 1 Excerpt

Somatostatin receptor SPECT

European Journal of Nuclear Medicine and Molecular Imaging • 2011

Similar Papers

Loading similar papers…